(Q35572368)

8 August 2017

1 reference

title

Pharmacodynamic monitoring of cyclosporin (English)

1 reference

8 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1458762

28 September 2022

1 reference

W. M. Awni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1458762

28 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1458762

28 September 2022

publication date

1 December 1992

1 reference

Clinical Pharmacokinetics

8 August 2017

1 reference

8 August 2017

23

1 reference

8 August 2017

6

1 reference

8 August 2017

428-448

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199223060-00004

8 August 2017

0 references

cites work

Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters

1 reference

12 December 2020

Significance of cyclosporine pharmacokinetics.

1 reference

12 December 2020

Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine

1 reference

12 December 2020

Monitoring of cyclosporine therapy with in vitro biological assays.

1 reference

12 December 2020

Onset and development of cyclosporin A effects on lymphocytes of cardiac patients before heart transplantation

1 reference

12 December 2020

The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients

1 reference

12 December 2020

Effects of cyclosporin A on the immune system of the mouse. I. Evidence for a direct selective effect of cyclosporin A on B cells responding to anti-immunoglobulin antibodies.

1 reference

12 December 2020

Immunological and pharmacological monitoring in the clinical use of cyclosporin A

1 reference

12 December 2020

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

12 December 2020

Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization

1 reference

12 December 2020

Cyclophilin, a primary molecular target for cyclosporine. Structural and functional implications

1 reference

12 December 2020

The value of serial serum trough cyclosporine levels in human renal transplantation

1 reference

12 December 2020

Cyclosporin A and prednisolone do not inhibit the expression of high-affinity receptors for interleukin 2

1 reference

12 December 2020

Prediction of acute graft rejection in renal transplantation: the utility of cyclosporine blood concentrations

1 reference

12 December 2020

Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients

1 reference

12 December 2020

Pharmacology of cyclosporine (sandimmune). III. Immunochemistry and monitoring

1 reference

12 December 2020

Beta 2-microglobulin: its significance in the evaluation of renal function

1 reference

12 December 2020

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

1 reference

12 December 2020

Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity

1 reference

12 December 2020

Pharmacokinetics of cyclosporine in toxicological studies

1 reference

12 December 2020

Adverse reactions and interactions of cyclosporin

1 reference

12 December 2020

Urine i-TXB2 in renal allograft rejection

1 reference

12 December 2020

Interleukin 6 (IL-6) in serum and urine of renal transplant recipients

1 reference

12 December 2020

Usefulness of serum interleukin 2 receptor levels in renal allograft recipients

1 reference

12 December 2020

Effect of cyclosporine A on the distal nephron: the use of kallikrein as a specific morphological marker

1 reference

12 December 2020

Pharmacology of cyclosporine (sandimmune). V. Pharmacological effects on immune function: in vitro studies

1 reference

12 December 2020

B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression

1 reference

12 December 2020

Molecular characteristics of cyclophilin-cyclosporine interaction

1 reference

12 December 2020

Induction of Interleukin 2 Messenger RNA Inhibited by Cyclosporin A

1 reference

12 December 2020

Tubular markers in renal transplant patients under cyclosporine.

1 reference

12 December 2020

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon

1 reference

12 December 2020

Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients

1 reference

12 December 2020

Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production

1 reference

12 December 2020

Area-under-the-curve monitoring of cyclosporine therapy: performance of different assay methods and their target concentrations

1 reference

12 December 2020

Cyclosporine blood level monitoring: the early posttransplant period

1 reference

12 December 2020

The fluid phase of coagulation and the accelerated atherosclerosis of diabetes mellitus

1 reference

12 December 2020

Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts

1 reference

12 December 2020

Clinical pharmacology of cyclosporine

1 reference

12 December 2020

Cyclosporine A: a clinical evaluation of drug interactions

1 reference

12 December 2020

Biological effects of cyclosporin A: A new antilymphocytic agent

1 reference

12 December 2020

Pharmacodynamic assays of the immunosuppressive action of cyclosporine therapy in transplant recipients

1 reference

12 December 2020

Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production in cyclosporine-treated and conventionally immunosuppressed human allograft recipients

1 reference

12 December 2020

Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR

1 reference

12 December 2020

Altered Factor VIII in Acute Respiratory Failure

1 reference

12 December 2020

Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation

1 reference

12 December 2020

Endothelial cells and the biology of factor VIII.

1 reference

12 December 2020

Therapeutic drug monitoring of cyclosporin. Practical applications and limitations

1 reference

12 December 2020

The cellular target of cyclosporin A action in humans

1 reference

12 December 2020

Cyclosporin A mediated immunosuppression in vitro: effect on high affinity interleukin-2 receptor expression and -turnover

1 reference

12 December 2020

Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephrotoxicity

1 reference

12 December 2020

Urinary enzyme analysis in renal allograft transplantation.

1 reference

12 December 2020

Morphologic diagnosis of cyclosporine nephrotoxicity

1 reference

12 December 2020

Urinary thromboxane (TxA2) reflects dose-response tissue injury in humans.

1 reference

12 December 2020

Influence of in vivo immunosuppressive drugs on production of lymphokines

1 reference

12 December 2020

Antiviral activity appearing in serum of renal transplant recipients. Its possible relation to immunological rejection

1 reference

12 December 2020

Cyclosporine--mechanism of action

1 reference

12 December 2020

Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression

1 reference

12 December 2020

Renal side-effects of cyclosporine

1 reference

12 December 2020

Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy

1 reference

12 December 2020

Cyclosporine nephrotoxicity

1 reference

12 December 2020

Urinary N-acetyl-beta-D-glucosaminidase and aminopeptidase N in the diagnosis of graft rejection after live donor renal transplantation

1 reference

12 December 2020

Diagnostic Significance of Standardized Determination of Urinary Enzymes1 in the Practice of Human Kidney Transplantation and Renal Toxicology

1 reference

12 December 2020

Interleukin 2 production by peripheral blood lymphocytes in allograft recipients during acute rejection episodes

1 reference

12 December 2020

Interleukin-6 serum levels correlate with footpad swelling in adjuvant-induced arthritic Lewis rats treated with cyclosporin A or indomethacin

1 reference

12 December 2020

Renal effects of cyclosporine.

1 reference

12 December 2020

Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A

1 reference

12 December 2020

Selective inhibition of immunoregulatory cell functions by cyclosporin A

1 reference

12 December 2020

Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C

1 reference

12 December 2020

Immunopharmacodynamic evaluation of cyclosporine-treated renal allograft recipients

1 reference

12 December 2020

In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A.

1 reference

12 December 2020

Contingent genetic regulatory events in T lymphocyte activation

1 reference

12 December 2020

Effects of the new anti-lymphocytic peptide cyclosporin A in animals

1 reference

12 December 2020

Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients

1 reference

12 December 2020

Gamma-interferon production capacity and T lymphocyte subpopulation after allogeneic bone marrow transplantation

1 reference

12 December 2020

Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury

1 reference

12 December 2020

Diagnostic significance of some urinary enzymes for detecting acute rejection crises in renal-transplant recipients: alanine aminopeptidase, alkaline phosphatase, gamma-glutamyltransferase, N-acetyl-beta-D-glucosaminidase, and lysozyme

1 reference

12 December 2020

Immunologic parameters of response in patients with rheumatoid arthritis treated with cyclosporin A

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of cyclosporine

1 reference

12 December 2020

Evidence that the soluble interleukin 2 receptor level may determine the optimal time for cystoscopically-directed biopsy in pancreaticoduodenal allograft recipients.

1 reference

12 December 2020

A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues

1 reference

12 December 2020

Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition

1 reference

12 December 2020

Clinical pharmacokinetics of cyclosporin

1 reference

12 December 2020

Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo

1 reference

12 December 2020

Immune mechanisms in organ allograft rejection. VI. Delayed-type hypersensitivity and lymphotoxin in experimental renal allograft rejection

1 reference

12 December 2020

Comparison of urinary N-acetyl-β-d-glucosaminidase and urinary fibrin degradation products for diagnosis of rejection after renal transplantation

1 reference

12 December 2020

The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection

1 reference

12 December 2020

Subcellular localization of renal kallikrein by ultrastructural immunocytochemistry

1 reference

12 December 2020

Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection

1 reference

12 December 2020

Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).

1 reference

12 December 2020

Indicators of acute renal-transplant rejection in patients treated with cyclosporine

1 reference

12 December 2020

Pharmacology and pharmacokinetics of cyclosporine

1 reference

12 December 2020

Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients

1 reference

12 December 2020

IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells

1 reference

12 December 2020

Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies

1 reference

12 December 2020

Sequential interleukin 2 and interleukin 2 receptor levels distinguish rejection from cyclosporine toxicity in liver allograft recipients

1 reference

12 December 2020

Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring

1 reference

12 December 2020

Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring

1 reference

12 December 2020

Thrombomodulin is present in human plasma and urine

1 reference

12 December 2020

Cyclosporine nephrotoxicity: pathogenesis, prophylaxis, therapy, and prognosis

1 reference

12 December 2020

Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo.

1 reference

12 December 2020

Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases

1 reference

12 December 2020

Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity

1 reference

12 December 2020

Cyclosporine: structure, pharmacokinetics, and therapeutic drug monitoring

1 reference

12 December 2020

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription

1 reference

12 December 2020

A prospective study of the clinical utility of lymphocyte monitoring in the cardiac transplant recipient

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic studies of cyclosporine in bone marrow transplantation

1 reference

12 December 2020

Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study

1 reference

12 December 2020

Pharmacodynamics of cyclosporine

1 reference

12 December 2020

Biotransformation and distribution in blood of cyclosporine and its metabolites

1 reference

12 December 2020

Interleukin 2, interferon, and lymphotoxin in renal transplant recipients

1 reference

12 December 2020

Use of beta 2 microglobulin to diagnose tubulo-interstitial renal lesions in children

1 reference

12 December 2020

Effects of cyclosporine on the immune system of the mouse. II. Cyclosporine inhibits the effector function of primary T helper cells, but not helper cell priming

1 reference

12 December 2020

Chronic renal tubular effects in relation to urine cadmium levels

1 reference

12 December 2020

Diagnosis of tubular injury in renal transplant patients by a urinary assay for a proximal tubular antigen, the adenosine-deaminase-binding protein

1 reference

12 December 2020

Urinary thromboxane excretion in cardiac allograft rejection in immunosuppressed rats

1 reference

12 December 2020

Soluble interleukin-2 receptor level as an indicator of liver allograft rejection

1 reference

12 December 2020

Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation

1 reference

12 December 2020

Sensitivity of monocyte subpopulations to cyclosporine. Arachidonate metabolism and in vitro antigen presentation

1 reference

12 December 2020

Urine immunoreactive thromboxane B2 in rat cardiac allograft rejection

1 reference

12 December 2020

The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system

1 reference

12 December 2020

10.2165/00003088-199223060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference